Tag Archives: Obalon Therapeutics
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Obalon Therapeutics, Inc. [NASDAQ: OBLN]
Oklahoma City, OK (March 6, 2018) – On February 14, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of California against Obalon Therapeutics, Inc. (NASDAQ: OBLN). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of… Read More »